OTC: SYGGF - Synairgen plc

Lønnsomhet i seks måneder: -30.91%
Sektor: Healthcare

Kampanjeplan Synairgen plc

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet

Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; and IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease. The company was incorporated in 2004 and is headquartered in Southampton, the United Kingdom.

Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета gbp
Сайт https://www.synairgen.com
Цена ао 0.042
Prisendring per dag: -7.32% (0.041)
Prisendring per uke: +18.75% (0.032)
Prisendring per måned: -5% (0.04)
Prisendring over 3 måneder: -9.52% (0.042)
Prisendring over seks måneder: -30.91% (0.055)
Prisendring per år: -24% (0.05)
Prisendring over 3 år: -98.53% (2.58)
Prisendring over 5 år: 0% (0.038)
Prisendring over 10 år: 0% (0.038)
Prisendring siden begynnelsen av året: -44.12% (0.068)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 0 0
P/BV 0.8498 9
P/E 0 0
EV/EBITDA -0.0235 0
Total: 3.63

Effektivitet

Navn Betydning Karakter
ROA, % -59.12 0
ROE, % -66.43 0
Total: 0

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA 0 10
Total: 9.6

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % -32.26 0
Lønnsomhet Ebitda, % 120.76 10
Lønnsomhet EPS, % -23.11 0
Total: 6
Flere detaljer

Institusjoner Volum Dele, %
Schwab Capital Trust-Laudus International Market Masters Fund 207041 0.1



Veileder Stillingstittel Betaling Fødselsår
Mr. Richard Marsden CEO, MD & Executive Director 412.77k 1967 (58 år)
Prof. Stephen T. Holgate CBE, M.D. Co-Founder, Non-Executive Director & Member of Scientific Advisory Board 55.37k 1947 (78 år)
Dr. Phillip David Monk Chairman of Scientific Advisory Board, Chief Scientific Officer & Executive Director 302.03k 1969 (56 år)
Prof. Donna Davies Co-Founder & Member of Scientific Advisory Board N/A
Prof. Ratko Djukanovic Co-Founder & Member of Scientific Advisory Board N/A
Mr. Joseph Tregonning Colliver F.C.A. CFO & Executive Director N/A 1980 (45 år)
Dr. Gareth E. Walters Ph.D. Chief Regulatory Officer N/A 1959 (66 år)
Ms. Jody Brookes Senior VP & Head of Clinical Operations N/A
Mr. Richard Francis Senior VP and Head of CMC & Quality N/A
Dr. Victoria Tear Head of Laboratory N/A

Adresse: United Kingdom, Southampton, Mailpoint 810 - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.synairgen.com